Oral anticoagulation in patients with "hemorrhagic-prone" vasculopathies: Overestimated risk?

Luis F Maia¹, Duncan Wilson¹

• ¹From Serviço de Neurologia (L.F.M.), Hospital de Santo António, Centro Hospitalar Universitário do Porto and Instituto de Biologia Molecular e Celular, Instituto de Investigação e Inovação em Saúde Universidade do Porto, Portugal; and Stroke Research Centre (D.W.), University College London and New Zealand Brain Research Institute, Christchurch, New Zealand.